Better communication reduces prescriptions for antibiotics

April 2, 2013
Better communication reduces prescriptions for antibiotics
Neither C-reactive protein testing nor enhanced physician communication training resulted in reduced office visits, but enhanced communication training resulted in less prescribing for antibiotics for respiratory tract infections, according to research published in March/April issue in Annals of Family Medicine.

(HealthDay)—Neither C-reactive protein testing nor enhanced physician communication training resulted in reduced office visits, but enhanced communication training resulted in less prescribing for antibiotics for respiratory tract infections, according to research published in March/April issue in Annals of Family Medicine.

Jochen W.L. Cals, M.D., Ph.D., of Maastricht University Medical Centre in the Netherlands, and colleagues conducted a clustered, randomized controlled study with a 3.5 year follow-up to assess the long-term effect of family physicians' use of C-reactive protein (CRP) point-of-care testing and/or enhanced physician communication skills on office visit rates and for respiratory tract infections.

According to the researchers, there were no differences in the mean number of physician per patient per year (PPPY) visits for respiratory tract infections between CRP and no CRP testing. The mean number of respiratory tract infections was 0.36 and 0.57 PPPY in the enhanced physician communication training group and no training group, respectively, (P=0.09). Antibiotic prescriptions were similar between CRP and no CRP test groups. Significantly fewer episodes of respiratory tract infection were treated by antibiotics in trained in communication skills than those without training, 26.3 percent versus 39.1 percent (P=0.02).

"Training physicians in the use of enhanced communication skills may have a wider long-term effect on the treatment of beyond acute cough to include reduced antibiotic prescribing," the authors write.

One author disclosed receiving travel or speaking fees from two manufacturers of point-of-care C-reactive protein devices.

Explore further: Children who have their adenoids out do not get fewer upper respiratory infections

More information: Abstract
Full Text

Related Stories

Black children less likely to be prescribed antibiotics

March 18, 2013

(HealthDay)—Black children are less likely to be prescribed antibiotics and to be diagnosed with conditions that require antibiotics, even when treated by the same doctor, according to research published online March 18 ...

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.